JOHN LAYMON: Open Payments
NPI 1154581452 · APO, AE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$88 in 3 payments from 2 companies in 2025. Trend: 2023 $0 · 2024 $72 · 2025 $88
Food & beverage: $88
| Company | Payments | Amount |
|---|---|---|
| Merz Pharmaceuticals, LLC | 2 | $58 |
| MicroTransponder, Inc. | 1 | $30 |
Products named: Xeomin.
Industry payments across AE — which companies pay providers there.
